The application of recombinant human collagen in tissue engineering

BioDrugs

Volumn 18, Issue 2, 2004, Pages 103-119

  Yang, Chunlin ^a   Hillas, Patrick J ^a   Báez, Julio A ^a   Nokelainen, Minna ^a   Balan, Juliana ^a   Tang, James ^a   Spiro, Robert ^a   Polarek, James W ^a  

^a FIBROGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 12; COLLAGEN TYPE 13; COLLAGEN TYPE 14; COLLAGEN TYPE 15; COLLAGEN TYPE 16; COLLAGEN TYPE 17; COLLAGEN TYPE 18; COLLAGEN TYPE 19; COLLAGEN TYPE 2; COLLAGEN TYPE 20; COLLAGEN TYPE 21; COLLAGEN TYPE 22; COLLAGEN TYPE 23; COLLAGEN TYPE 24; COLLAGEN TYPE 25; COLLAGEN TYPE 26; COLLAGEN TYPE 27; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; COLLAGEN TYPE 7; COLLAGEN TYPE 8; COLLAGEN TYPE 9; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BIOCOMPATIBILITY; BONE GRAFT; CARTILAGE; CELL INTERACTION; COLLAGEN SYNTHESIS; COMPOSITE SKIN GRAFT; CONNECTIVE TISSUE; DENTISTRY; DISEASE TRANSMISSION; HUMAN; HYDROXYLATION; MOLECULAR INTERACTION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; QUALITY CONTROL; RECOMBINANT DNA TECHNOLOGY; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; BIOCOMPATIBLE MATERIALS; COLLAGEN; HUMANS; RECOMBINANT PROTEINS; TISSUE ENGINEERING;

EID: 1942441377     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200418020-00004     Document Type: Review

References (183)

1. Chapekar MS. Tissue engineering: challenges and opportunities. J Biomed Mater Res 2000; 53 (6): 617-20
2. Fox CF, Skalak R. Tissue engineering. New York: John Wiley and Sons, 1988
3. Godbey WT, Atala A. In vitro systems for tissue engineering. Ann N Y Acad Sci 2002; 961: 10-26
4. Griffith LG. Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann N Y Acad Sci 2002; 961: 83-95
5. Lysaght MJ, Reyes J. The growth of tissue engineering. Tissue Eng 2001; 7 (5): 485-93
6. Makarand V. Tissue engineering: advances in in vitro cartilage generation. Trends Biotechnol 2002; 20 (8): 351-6
7. Pearson RG, Bhandari R, Quirk RA, et al. Recent advances in tissue engineering: an invited review. J Long Term Eff Med Implants 2002; 12 (1): 1-33
8. Vunjak-Novakovic G, Obradovic B, Martin I, et al. Bioreactor studies of native and tissue engineered cartilage. Biorheology 2002; 39 (1-2): 259-68
9. Blunk T, Sieminski AL, Gooch KJ, et al. Differential effects of growth factors on tissue-engineered cartilage. Tissue Eng 2002; 8 (1): 73-84
10. Pei M, Seidel J, Vunjak-Novakovic G, et al. Growth factors for sequential cellular de-and re-differentiation in tissue engineering. Biochem Biophys Res Commun 2002; 294: 149-54
11. vVan Osch GJ, Mandl EW, Marijnissen WJ, et al. Growth factors in cartilage tissue engineering. Biorheology 2002; 39 (1-2): 215-20
12. Silver FH, Pins G. Cell growth on collagen: a review of tissue engineering using scaffolds containing extracellular matrix. J Long Term Eff Med Implants 1992; 2 (1): 67-80
13. Altman GH, Diaz F, Jakuba C, et al. Silk-based biomaterials. Biomaterials 2003; 24 (3): 401-16
14. Altman GH, Horan RL, Lu HH, et al. Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials 2002; 23 (20): 4131-41
15. Berisio R, Vitagliano L, Mazzarella L, et al. Recent progress on collagen triple helix structure, stability and assembly. Protein Pept Lett 2002; 9 (2): 107-16
16. Brodsky B, Ramshaw JA. The collagen triple-helix structure. Matrix Biol 1997; 15 (8-9): 545-54
17. Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann Med 2001; 33 (1): 7-21
18. Patino MG, Neiders ME, Andreana S, et al. Collagen: an overview. Implant Dent 2002; 11 (3): 280-5
19. Ramshaw J, Werkmeister J, Glattauner V. Collagen-based biomaterials. Biotechol Genet Eng Rev 1996; 13: 335-82
20. Bateman JF, Lamandé SR, Ramshaw JAM. Collagen superfamily. In: Comper WD, editor. Extracellular matrix. Amsterdam: Harwood Academic Publishers, 1996: 22-67
21. Brown JC, Timpl R. The collagen superfamily. Int Arch Allergy Immunol 1995; 107 (4): 484-90
22. Chevallay B, Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: application for tissue engineering and gene therapy. Med Biol Eng Comput 2000; 38: 211-8
23. Eyre DR. Collagen: molecular diversity in the body's protein scaffold. Science 1980; 207 (4437): 1315-22
24. Kadler K. Extracellular matrix 1: fibril-forming collagens. Protein Profile 1995; 2 (5): 491-619
25. Kemp PD. Tissue engineering and cell-populated collagen matrices. Methods Mol Biol 2000; 139: 287-93
26. Lee CH, Singla A, Lee Y. Biomedical applications of collagen. Int J Pharm 2001; 221 (1-2): 1-22
27. Lin CQ, Bissell MJ. Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 1993; 7 (9): 737-43
28. Patino MG, Neiders ME, Andreana S, et al. Collagen as an implantable material in medicine and dentistry. J Oral Implantol 2002; 28 (5): 220-5
29. Prockop D, Kivirikko K. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995; 64: 403-34
30. Ricard-Blum S, Dublet B, van der Rest M. Unconventional collagens. New York: Oxford University Press, 2000
31. Wong Po FC, Kaplan DL. Genetic engineering of fibrous proteins: spider dragline silk and collagen. Adv Drug Deliv Rev 2002; 54 (8): 1131-43
32. Yang C, Li SW, Helminen HJ, et al. Apoptosis of chondrocytes in transgenic mice lacking collagen II. Exp Cell Res 1997; 235 (2): 370-3
33. Bonnet C, Charriere G, Vaquier J, et al. Bovine collagen induced systemic symptoms: antibody formation against bovine and human collagen. J Rheumatol 1996; 23 (3): 545-7
34. Charriere G, Bejot M, Schnitzler L, et al. Reactions to a bovine collagen implant: clinical and immunologic study in 705 patients. J Am Acad Dermatol 1989; 21 (6): 1203-8
35. Cooperman L, Michaeli D. The immunogenicity of injectable collagen: I. A 1-year prospective study. J Am Acad Dermatol 1984; 10 (4): 638-46
36. Meade KR, Silver FH. Immunogenicity of collagenous implants. Biomaterials 1990; 11 (3): 176-80
37. Patino MG, Neiders ME, Andreana S, et al. Cellular inflammatory response to porcine collagen membranes. J Periodontal Res 2003; 38 (5): 458-64
38. Asher DM. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics. Dev Biol Stand 1999; 100: 103-18
39. Hartmann DJ, Charriere G, Ricard-Blum S, et al. Immunogenicity of injectable collagen implants [letter]. J Dermatol Surg Oncol 1990; 16 (4): 394
40. Hellman KB, Honstead JP, Vincent CK. Adventitious agents from animal-derived raw materials and production systems. Dev Biol Stand 1996; 88: 231-4
41. Miekka SI, Forng RY, Rohwer RG, et al. Inactivation of viral and prion pathogens by gamma-irradiation under conditions that maintain the integrity of human albumin. Vox Sang 2003; 84 (1): 36-44
42. Schrieber R, Seybold U. Gelatine production, the six steps to maximum safety. Dev Biol Stand 1993; 80: 195-8
43. Bulleid NJ, John DC, Kadler KE. Recombinant expression systems for the production of collagen. Biochem Soc Trans 2000; 28 (4): 350-3
44. Chapman WC, Sherman R, Boyce S. A novel collagen-based composite offers effective hemostasis for multiple surgical indications: results of a randomized controlled trial. Surgery 2001; 129 (4): 445-50
45. Chapman WC, Wren SM, Lebovic GS, et al. Effective management of bleeding during tumor resection with a collagen-based hemostatic agent. Am Surg 2002; 68 (9): 802-7
46. Green JG, Durham TM. Application of INSTAT hemostat in the control of gingival hemorrhage in the patient with thrombocytopenia: a case report. Oral Surg Oral Med Oral Pathol 1991; 71 (1): 27-30
47. Kheirabadi BS, Field-Ridley A, Pearson R. Comparative study of the efficacy of the common topical hemostatic agents with fibrin sealant in a rabbit aortic anastomosis model. J Surg Res 2002; 106: 99-107
48. Martinez L, Ros Z, Lopez-Gutierrez JC, et al. Integra artificial dermis in pediatric reconstructive surgery. Cir Pediatr 2002; 15 (3): 97-100
49. Ozerdem OR, Wolfe SA, Marshall D. Use of skin substitutes in pediatrie patients. J Craniofac Surg 2003; 14 (4): 517-20
50. Palao R, Gomez P, Huguet P. Burned breast reconstructive surgery with Integra dermal regeneration template. Br J Plast Surg 2003; 56 (3): 252-9
51. Papp A, Harma M. A collagen based dermal substitute and the modified Meek technique in extensive bums: report of three cases. Burns 2003; 29 (2): 167-71
52. Quarmby JW, Burnand KG, Lockhart SJM, et al. Prospective randomized trial of woven versus collagen-impregnated knitted prosthetic Dacron grafts in aortoiliac surgery. Br J Surg 1998; 85: 775-7
53. Sclafani AP, Romo T. Injectable fillers for facial soft tissue enhancement. Facial Plast Surg 2000; 16 (1): 29-33
54. Wallace D, McPherson J, Ellingsworth L. In: Nimni ME, editor. Collagen. Boca Raton (FL): CRC Press, 1988: 117-44
55. Wisser D, Steffes J. Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma. Burns 2003; 29 (4): 375-80
56. Cheng EL, Maruyama I, SundarRaj N, et al. Expression of type XII collagen and hemidesmosome-associated proteins in keratoconus corneas. Curr Eye Res 2001; 22 (5): 333-40
57. Vaughn PR, Galanis M, Richards KM, et al. Production of recombinant hydroxylated human type III collagen fragment in Saccharomyces cerevisiae. DNA Cell Biol 1998; 17 (6): 511-8
58. Berisio R, Vitagliano L, Mazzarella L, et al. Crystal structure of the collagen triple helix model [(Pro-Pro-Gly)(10)](3). Protein Sci 2002; 11 (2): 262-70
59. Banyard J, Bao L, Zetter BR. Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. J Biol Chem 2003; 278 (23): 20989-94
60. Boot-Handford RP, Tuckwell DS, Plumb DA, et al. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol Chem 2003; 278 (33): 31067-77
61. Chanut-Delalande H, Fichard A, Bernocco S, et al. Control of heterotypic fibril formation by collagen V is determined by chain stoichiometry. J Biol Chem 2001; 276 (26): 24352-9
62. Diab M, Wu JJ, Eyre DR. Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. Biochem J 1996; 314 (R 1): 327-32
63. Eyre D. Collagen of articular cartilage. Arthritis Res 2002; 4 (1): 30-5
64. Eyre DR, Wu JJ, Fernandes RJ, et al. Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans 2002; 30 (Pt 6): 893-9
65. Fernandes RJ, Schmid TM, Eyre DR. Assembly of collagen types II, IX and XI into nascent hetero-fibrils by a rat chondrocyte cell line. Eur J Biochem 2003; 270 (15): 3243-50
66. Fertala A, Sieron AL, Ganguly A, et al. Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080). Biochem J 1994; 298 (Pt 1): 31-7
67. Fertala A, Sieron AL, Adachi E, et al. Collagen II containing a Cys substitution for Arg-alpha1-519: abnormal interactions of the mutated molecules with collagen IX. Biochemistry 2001; 40: 14422-8
68. Fitzgerald J, Bateman JF. A new FACIT of the collagen family: COL21A1. FEBS Lett 2001; 505 (2): 275-80
69. Hashimoto T, Wakabayashi T, Watanabe A, et al. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J 2002; 21 (7): 1524-34
70. Ichimura S, Wu JJ, Eyre DR. Two-dimensional peptide mapping of cross-linked type IX collagen in human cartilage. Arch Biochem Biophys 2000; 378 (1): 33-9
71. Keizer-Gunnink I, Vuorela A, Myllyharju J, et al. Accumulation of properly folded human type III procollagen molecules in specific intracellular membranous compartments in the yeast Pichia pastoris. Matrix Biol 2000; 19 (1): 29-36
72. Koch M, Foley JE, Hahn R, et al. Alpha 1(Xx) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted triple helices. J Biol Chem 2001; 276 (25): 23120-6
73. Koch M, Laub F, Zhou P, et al. Collagen XXIV, a vertebrate fibrillar collagen with structural features of invertebrate collagens: selective expression in developing cornea and bone. J Biol Chem 2003; 278 (44): 43236-44
74. Matsui Y, Wu JJ, Weis MA, et al. Matrix deposition of tryptophan-containing allelic variants of type IX collagen in developing human cartilage. Matrix Biol 2003; 22 (2): 123-9
75. Mazzorana M, Snellman A, Kivirikko KI, et al. Involvement of prolyl 4-hydroxylase in the assembly of trimeric minicollagen XII: study in a baculovirus expression system. J Biol Chem 1996; 271 (46): 29003-8
76. Myllyharju J, Nokelainen M, Vuorela A, et al. Expression of recombinant human type I-III collagens in the yeast Pichia pastoris. Biochem Soc Trans 2000; 28 (4): 353-7
77. Niyibizi C, Eyre DR. Structural characteristics of cross-linking sites in type V collagen of bone: chain specificities and heterotypic links to type I collagen. Eur J Biochem 1994; 224 (3): 943-50
78. Olsen DR, Leigh SD, Chang R, et al. Production of human type I collagen in yeast reveals unexpected new insights into the molecular assembly of collagen trimers. J Biol Chem 2001; 276 (26): 24038-43
79. Sato K, Yomogida K, Wada T, et al. Type XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary. J Biol Chem 2002; 277 (40): 37678-84
80. Toman PD, Pieper F, Sakai N, et al. Production of recombinant human type I procollagen homotrimer in the mammary gland of transgenic mice. Transgenic Res 1999; 8: 415-27
81. Tuckwell D. Identification and analysis of collagen alpha 1 (XXI), a novel member of the FACIT collagen family. Matrix Biol 2002; 21 (1): 63-6
82. Klionsky D, Banta L. Intracellular sorting and processing of a yeast vacuolar hydrolase: proteinase A propeptide contains vacuolar targeting information. Mol Cell Biol 1988; 8 (5): 2105-16
83. Vuorela A, Myllyharju I, Nissi R, et al. Assembly of human prolyl 4-hydroxylase and type III collagen in the yeast Pichia pastoris: formation of a stable enzyme tetramer requires coexpression with collagen and assembly of a stable collagen requires coexpression with prolyl 4-hydroxylase. EMBO J 1997; 16: 6702-12
84. Wu JJ, Eyre DR. Structural analysis of cross-linking domains in cartilage type XI collagen: insights on polymeric assembly. J Biol Chem 1995; 270 (32): 18865-70
85. Hulmes DJ. The collagen superfamily: diverse structures and assemblies. Essays Biochem 1992; 27: 49-67
86. Kishore U, Reid KB. C1q: structure, function, and receptors. Immunopharmacology 2000; 49 (1-2): 159-70
87. Trinder PK, Maeurer MJ, Brackertz D, et al. The collagen-like component of the complement system, C1q, is recognized by 7 S autoantibodies and is functionally impaired in synovial fluids of patients with rheumatoid arthritis. Immunology 1996; 87 (3): 355-61
88. Kurata H, Cheng HM, Kozutsumi Y, et al. Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin. Biochem Biophys Res Commun 1993; 191 (3): 1204-10
89. Matsushita M, Endo Y, Taira S, et al. A novel human serum lectin with collagen-and fibrinogen-like domains that functions as an opsonin. J Biol Chem 1996; 271 (5): 2448-54
90. Eda S, Suzuki Y, Kase T, et al. Recombinant bovine conglutinin, lacking the N-terminal and collagenous domains, has less conglutination activity but is able to inhibit haemagglutination by influenza A virus. Biochem J 1996; 316 (Pt 1): 43-8
91. Kolble K, Reid KB. The genomics of soluble proteins with collagenous domains: C1q, MBL, SP-A, SP-D, conglutinin, and CL-43. Behring Inst Mitt 1993; (93): 81-6
92. Reid KB, Colomb M, Petry F, et al. Complement component C1 and the collectins: first-line defense molecules in innate and acquired immunity. Trends Immunol 2002; 23 (3): 115-7
93. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109 (6): 707-12
94. Kishore U, Reid KB. Structures and functions of mammalian collectins. Results Probl Cell Differ 2001; 33: 225-48
95. Reid KB. Structure/function relationships in the collectins (mammalian lectins containing collagen-like regions). Biochem Soc Trans 1993; 21 (2): 464-8
96. Lu J, Le Y. Ficolins and the fibrinogen-like domain. Immunobiology 1998; 199 (2): 190-9
97. Matsushita M, Fujita T. Ficolins and the lectin complement pathway. Immunol Rev 2001; 180: 78-85
98. Kivirikko KI. Collagen biosynthesis: a mini-review cluster. Matrix Biol 1998; 16 (7): 355-6
99. Tandon M, Wu M, Begley TP, et al. Substrate specificity of human prolyl-4-hydroxylase. Bioorg Med Chem Lett 1998; 8 (10): 1139-44
100. Vuori K, Pihlajaniemi T, Marttila M, et al. Characterization of the human prolyl 4-hydroxylase tetramer and its multifunctional protein disulfide-isomerase subunit synthesized in a baculovirus expression system. Proc Natl Acad Sci U S A 1992; 89 (16): 7467-70
101. Rautavuoma K, Takaluoma K, Passoja K, et al. Characterization of three fragments that constitute the monomers of the human lysyl hydroxylase isoenzymes 1-3: the 30-kDa N-terminal fragment is not required for lysyl hydroxylase activity. J Biol Chem 2002; 277 (25): 23084-91
102. Heikkinen J, Risteli M, Wang C, et al. Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. J Biol Chem 2000; 275 (46): 36158-63
103. Puistola U, Turpeenniemi-Hujanen TM, Myllyla R, et al. Studies on the lysyl hydroxylase reaction: II. Inhibition kinetics and the reaction mechanism. Biochim Biophys Acta 1980; 611 (1): 51-60
104. Kivirikko KI. Posttranslational Processing of Collagens. In: Bittar EE, Bittar N, editors. Principles of medical biology. Cellular organelles and the extracellular matrix. London: JAI Press, 1995: 233-54
105. Tuderman L, Prockop DJ. Procollagen N-proteinase: properties of the enzyme purified from chick embryo tendons. Eur J Biochem 1982; 125 (3): 545-9
106. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001; 70: 1-33
107. Kagan HM, Trackman PC. Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol 1991; 5 (3): 206-10
108. Kenyon K, Modi WS, Contente S, et al. A Novel Human cDNA with a Predicted Protein Similar to Lysyl Oxidase Maps to Chromosome 15q24-q25. J Biol Chem 1993; 268 (25): 18435-7
109. Kim M, Otsuka M, Shimamura E, et al. The effect of L-ascorbic acid on age-related changes of pyridinoline in cartilage collagen of guinea pigs. J Nutr Sci Vitaminol (Tokyo) 1998; 44 (2): 217-24
110. Pokharna HK, Phillips FM. Collagen crosslinks in human lumbar intervertebral disc aging. Spine 1998; 23 (15): 1645-8
111. Lauer-Fields JL, Juska D, Fields GB. Matrix metalloproteinases and collagen catabolism. Biopolymers 2002; 66 (1): 19-32
112. Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 2002; 22 (1): 51-86
113. Dung SZ. Effects of mutans streptococci, Actinomyces species and Porphyromonas gingivalis on collagen degradation. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62 (11): 764-74
114. Hynes RO, Bader BL, Hodivala-Dilke K. Integrins in vascular development. Braz J Med Biol Res 1999; 32: 501-10
115. Heino J. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 2000; 19 (4): 319-23
116. Zhang WM, Kapyla J, Puranen JS, et al. Alpha 11beta 1 integrin recognizes the GFOGER sequence in interstitial collagens. J Biol Chem 2003; 278 (9): 7270-7
117. Humphries M. Integrin structure. Biochem Soc Trans 2000; 28 (4): 311-40
118. Davis GE. Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun 1992; 182 (3): 1025-31
119. Schwartz MA. Integrin signaling revisited. Trends Cell Biol 2001; 11 (12): 466-70
120. Agarwal G, Kovac L, Radziejewski C, et al. Binding of discoidin domain receptor 2 to collagen I: an atomic force microscopy investigation. Biochemistry 2002; 41 (37): 11091-8
121. Vogel WF. Collagen-receptor signaling in health and disease. Eur J Dermatol 2001; 11 (6): 506-14
122. Koyama H, Raines EW, Bornfeldt KE, et al. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 1996; 87 (6): 1069-78
123. Cukierman E, Pankov R, Stevens DR, et al. Taking cell-matrix adhesions to the third dimension. Science 2001; 294 (5547): 1708-12
124. Gohari S, Gambia C, Healey M, et al. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol Surg 2002; 28 (12): 1107-14
125. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000; 25 (3): 376-81
126. Burkus JK, Transfeldt EE, Kitchel SH, et al. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002; 27 (21): 2396-408
127. Zyderm collagen implant, package insert [online]. Palo Alto (CA): Collagen Aesthetics (International) Ltd. Available from URL: http://www.inamed.com/ products/facial/us/patient/zz/prodinfo.html [Accessed 2003 Dec 19]
128. Avitene (r) Microfibrillar Collagen Hemostat, package insert [online]. Woburn (MA): MedChem Products Inc. Available from URL: http://www.davol.com/ HTMLFiles/Hemostasis/AviteneMicroInsert1.html [Accessed 2003 Dec 19]
129. Ala-Kokko L, Hyland J, Smith C, et al. Expression of a human cartilage procollagen gene (COL2A1) in mouse 3T3 cells. J Biol Chem 1991; 266 (22): 14175-8
130. Geddis AE, Prockop DJ. Expression of human COL1A1 gene in stably transfected HT1080 cells: the production of a thermostable homotrimer of type I collagen in a recombinant system. Matrix 1993; 13 (5): 399-405
131. Myllyharju J, Lamberg A, Notbohm H, et al. Expression of wild-type and modified proalpha chains of human type I procollagen in insect cells leads to the formation of stable [alphal(I)]2alpha2(I) collagen heterotrimers and [al-pha1(I)]3 homotrimers but not [alpha2(I)]3 homotrimers. J Biol Chem 1997; 272: 21824-30
132. Tomita M, Kitajima T, Yoshizato K. Formation of recombinant human procollagen I heterotrimers in a baculovirus expression system. J Biochem (Tokyo) 1997; 121 (6): 1061-9
133. Veijola J, Koivunen P, Annunen P, et al. Cloning, baculovirus expression, and characterization of the alpha subunit of prolyl 4-hydroxylase from the nematode Caenorhabditis elegans: this alpha subunit forms an active alpha beta dimer with the human protein disulfide isomerase/beta subunit. J Biol Chem 1994; 269 (43): 26746-53
134. Veijola J, Pihlajaniemi T, Kivirikko KI. Co-expression of the alpha subunit of human prolyl 4-hydroxylase with BiP polypeptide in insect cells leads to the formation of soluble and insoluble complexes: soluble alpha-subunit-BiP complexes have no prolyl 4-hydroxylase activity. Biochem J 1996; 315 (Pt 2): 613-8
135. de Bruin EC, Werten MWT, Laane C, et al. Endogenous prolyl 4-hydroxylation in Hansenula polymorpha and its use for the production of hydroxylated recombinant gelatin. FEMS Yeast Res 2002; 1: 291-8
136. Nokelainen M, Tu H, Vuorela A, et al. High-level production of human type I collagen in the yeast Pichia pastoris. Yeast 2001; 18: 797-806
137. Toman PD, Chisholm G, McMullin H, et al. Production of recombinant human type I procollagen trimers using a four-gene expression system in the yeast Saccharomyces cerevisiae. J Biol Chem 2000; 275 (30): 23303-9
138. Werten MW, van den Bosch TJ, Wind RD, et al. High-yield secretion of recombinant gelatins by Pichia pastoris. Yeast 1999; 15: 1087-96
139. Werten MW, Wisselink WH, Jansen-van den Bosch TJ, et al. Secreted production of a custom-designed, highly hydrophilic gelatin in Pichia pastoris. Protein Eng 2001; 14 (6): 447-54
140. John DCA, Watson A, Kind AJ, et al. Expression of an engineered form of recombinant procollagen in mouse milk. Nat Biotechnol 1999; 17: 385-9
141. Tomita M, Munetsuna H, Sato T, et al. Transgenic silkworms produce recombinant human type III procollagen in cocoons. Nat Biotechnol 2002; 21 (1): 52-6
142. Yang C, Bodo M, Chang R, et al. Development of recombinant gelatin by expression of recombinant collagen in yeast and plants [abstract]. American Association of Pharmaceutical Scientists Annual Meeting and Exposition; 1999 Nov 17; New Orleans
143. Merle C, Perret S, Lacour T, et al. Hydroxylated human homotrimeric collagen I in Agrobacterium tumefaciens-mediated transient expression and in transgenic tobacco plant. FEBS Lett 2002; 515 (1-3): 114-8
144. Ruggiero F, Exposito JY, Bournat P, et al. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants. FEBS Lett 2000; 469: 132-6
145. Pihlajaniemi T, Myllyla R, Kivirikko KI. Prolyl 4-hydroxylase and its role in collagen synthesis. J Hepatol 1991; 13 Suppl. 3: S2-7
146. Kivirikko KI, Pihlajaniemi T. Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases. Adv Enzymol Relat Areas Mol Biol 1998; 72: 325-98
147. Vuorela A, Myllyharju J, Pihlajaniemi T, et al. Coexpression with collagen markedly increases the half-life of the recombinant human prolyl 4-hydroxylase tetramer in the yeast Pichia pastoris. Matrix Biol 1999; 18 (5): 519-22
148. Suzuki K. Collagen derived from a porcine skin. Fragrance J 2001; 29 (11): 59-64
149. Olsen D, Yang C, Bodo M, et al. Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev 2003; 55: 1547-67
150. Nimni ME. Collagen: structure, function, and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum 1983; 13 (1): 1-86
151. Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001; 26 (8): 933-9
152. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003; 28 (5): 429-34
153. Burkus JK, Dorchak JD, Sanders DL. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 2003; 28 (4): 372-7
154. Cornell CN, Lane JM, Chapman M, et al. Multicenter trial of Collagraft as bone graft substitute. J Orthop Trauma 1991; 5 (1): 1-8
155. Walsh WR, Harrison J, Loefler A, et al. Mechanical and histologic evaluation of Collagraft in an ovine lumbar fusion model. Clin Orthop 2000; 375: 258-66
156. Tay BK, Le AX, Heilman M, et al. Use of a collagen-hydroxyapatite matrix in spinal fusion: a rabbit model. Spine 1998; 23 (21): 2276-81
157. McPherson JM, Wallace D, Sawamura S, et al. Collagen fibrilliogenesis in vitro: a characterization of fibril quality as a function of assembly conditions. Coll Relat Res 1985; 5: 2119-35
158. Grabarek Z, Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990; 185 (1): 131-5
159. Wong S. Chemistry of protein conjugation and crosslinking. Boca Raton (FL): CRC, 1991: 195-207
160. Process for fixation of calcification-resistant biological tissue. Girardot J-M, Girardot M-N, inventors; Biomedical Design, Inc., assignees. U.S. Patent No. 5,733,339. 1998 Mar 31
161. Method for fixation of biological tissue. Girardot, J-M, Girardot M-N, inventors; Biomedical Design, Inc, assignees. U.S. Patent No. 5,477,536 1995 Sep 5
162. Olde Damink LH, Dijkstra PJ, van Luyn MJ, et al. In vitro degradation of dermal sheep collagen cross-linked using a water-soluble carbodiimide. Biomaterials 1996; 17 (7): 679-84
163. van Wachem PB, van Luyn MJ, Olde Damink LH, et al. Tissue regenerating capacity of carbodiimide-crosslinked dermal sheep collagen during repair of the abdominal wall. Int J Artif Organs 1994; 17 (4): 230-9
164. Bellows CG, Aubin JE, Heersche JN, et al. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986; 38 (3): 143-54
165. Laurencin CT, Attawia MA, Elgendy HE, et al. Tissue engineered bone-regeneration using degradable polymers: the formation of mineralized matrices. Bone 1996; 19 (1 Suppl.): 93S-9S
166. Ali S. Matrix formation and mineralization in bone. In: Whitehead CC, editor. Bone biology and skeletal disorders in poultry. Oxford: Carfax Publishing, 1992: 19,38
167. Kassab MM, Cohen RE. The etiology and prevalence of gingival recession. J Am Dent Assoc 2003; 134 (2): 220-5
168. Kassab MM, Cohen RE. Treatment of gingival recession. J Am Dent Assoc 2002; 133 (11): 1499-506
169. Danesh-Meyer MJ, Chen ST, Rams TE. Digital subtraction radiographic analysis of GTR in human intrabony defects. Int J Periodontics Restorative Dent 2002; 22 (5): 441-9
170. Eisig SB, Ho V, Kraut R, et al. Alveolar ridge augmentation using titanium micromesh: an experimental study in dogs. J Oral Maxillofac Surg 2003; 61 (3): 347-53
171. Bunyaratavej P, Wang HL. Collagen membranes: a review. J Periodontol 2001; 72 (2): 215-29
172. Takeishi H, Irie K, Okuda K, et al. Molded bone augmentation by a combination of barrier membrane and recombinant human bone morphogenetic protein-2. Oral Dis 2001; 7 (5): 281-6
173. Scott DL, Shipley M, Dawson A, et al. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol 1998; 37 (5): 546-54
174. Brittberg M, Tallheden T, Sjogren-Jansson B, et al. Autologous chondrocytes used for articular cartilage repair: an update. Clin Orthop 2001; 391 Suppl.: S337-48
175. Fuss M, Ehlers EM, Russlies M, et al. Characteristics of human chondrocytes, osteoblasts and fibroblasts seeded onto a type I/III collagen sponge under different culture conditions: a light, scanning and transmission electron microscopy study. Anat Anz 2000; 182 (4): 303-10
176. Russlies M, Behrens P, Wunsch L, et al. A cell-seeded biocomposite for cartilage repair. Ann Anat 2002; 184 (4): 317-23
177. Lu L, Zhu X, Valenzuela RG, et al. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop 2001; 391 Suppl.: S251-70
178. Mast B. Wound healing: biochemical and clinical aspects. In: Cohen IK, Diegelmann RF, Lindlbad WJ, editors. The skin. Philadelphia (PA): W.B. Saunders, 2003
179. Bell E, Rosenberg M, Kemp P, et al. Recipes for reconstituting skin. J Biomech Eng 1991; 113 (2): 113-9
180. Heimbach D, Luterman A, Burke J, et al. Artificial dermis for major burns: a multi-center randomized clinical trial. Ann Surg 1988; 208 (3): 313-20
181. Yannas IV, Burke JF. Design of an artificial skin: I. Basic design principles. J Biomed Mater Res 1980; 14 (1): 65-81
182. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 1979; 76 (3): 1274-8
183. Hayashi M, Tomita M, Yoshizato K. Production of EGF-collagen chimeric protein which shows the mitogenic activity. Biochim Biophys Acta 2001; 1528 (2-3): 187-95